SCHEMBL9521799

SCHEMBL9521799

CC([O])OC(C)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083169 0.77
SCHEMBL270261 0.76
SCHEMBL6287791 0.74
SCHEMBL6238591 0.74
SCHEMBL19112682 0.69
SCHEMBL378117 0.69
SCHEMBL1333515 0.66
SCHEMBL10529090 0.64
SCHEMBL11125492 0.64
SCHEMBL147167 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0224173-B1 STEROIDAL GLYCOLIPIDS AS HOST RESISTANCE STIMULATORS MERCK & CO. INC. (US) 1993-04-28 EP disclosed
US-5019568-A Steroidal glycolipids as host resistance stimulators against viral infection MERCK & CO., INC. (US) 1991-05-28 US disclosed
US-4970199-A ADMINISTERING WITH ANTI-AIDS DRUGS MERCK & CO., INC. (US) 1990-11-13 US disclosed
US-4942154-A AIDS, VIRICIDES, IMMUNOLOGY MERCK & CO., INC. (US) 1990-07-17 US disclosed
EP-0224173-A1 Steroidal glycolipids as host resistance stimulators MERCK & CO. INC. (US) 1987-06-03 EP disclosed
US-4652637-A IMMUNOSTIMULANTS MERCK & CO., INC. (US) 1987-03-24 US disclosed
US-4652553-A IMMUNOSTIMULANTS MERCK & CO., INC. (US) 1987-03-24 US disclosed